TD Cowen downgraded Endava (DAVA) to Hold from Buy with a price target of $17, down from $27. The company’s downside to fiscal Q3 estimates and lowered Q4 outlook “marked another frustrating print” as it continues to “navigate a very challenging period,” the analyst tells investors in a research note. The firm now sees a limited revenue growth recovery and earnings expansion potential in the year ahead for Endava. As the company’s peers demonstrate more stability, investors will find more attractive alternatives, likely causing a prolonged stock recovery, contends TD.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA: